• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Ardent Health Partners Inc.

    11/14/24 4:27:52 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care
    Get the next $ARDT alert in real time by email
    SC 13G 1 sayw24111403_13g.htm




    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. )*

    Ardent Health Partners, Inc.
    (Name of Issuer)

    Common Stock, $0.01 par value per share
    (Title of Class of Securities)

    03980N107
    (CUSIP Number)

    September 30, 2024
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐   Rule 13d-1(b)
    ☐   Rule 13d-1(c)
    ☒   Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Continued on following pages
    Page 1 of 9 Pages
    Exhibit Index: Page 8



    CUSIP No. 03980N107
    SCHEDULE 13G
    Page 2 of 9 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    CHAI TRUST COMPANY, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Illinois
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    77,246,499
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    77,246,499
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    77,246,499
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    54.1%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    OO
     
     
     
     


    CUSIP No. 03980N107
    SCHEDULE 13G
    Page 3 of 9 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    EGI-AM Investments, L.L.C.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    77,246,499
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    77,246,499
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    77,246,499
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    54.1%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    OO
     
     
     
     


    CUSIP No. 03980N107
    SCHEDULE 13G
    Page 4 of 9 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    EGI-AM Investor, L.L.C.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    77,246,499
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    77,246,499
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    77,246,499
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    54.1%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    OO
     
     
     
     


    CUSIP No. 03980N107
    SCHEDULE 13G
    Page 5 of 9 Pages
    Item 1(a).
    Name of Issuer:

    Ardent Health Partners, Inc. (the “Issuer”)

    Item 1(b).
    Address of Issuer’s Principal Executive Offices:

    340 Seven Springs Way, Suite 100, Brentwood, Tennessee 37027

    Item 2(a).
    Name of Person Filing

    This Statement is filed on behalf of Chai Trust Company, LLC (“Chai Trust”), EGI-AM Investments, L.L.C. (“EGI-AM Investments”) and EGI-AM Investor, L.L.C. (“EGI-AM Investor” and, together with Chai Trust and EGI-AM Investments, the “Reporting Persons”).

    This Statement relates to the shares of Common Stock (as defined herein) held directly by EGI-AM Investments.  EGI-AM Investor is the manager of EGI-AM Investments, and Chai Trust is the managing member of EGI-AM Investor.  In such capacities, each of EGI-AM Investor and Chai Trust may be deemed to indirectly beneficially own the shares of Common Stock held directly by EGI-AM Investments.

    Item 2(b).
    Address of Principal Business Office or, if None, Residence:

    Two North Riverside Plaza, Suite 600, Chicago, Illinois 60606

    Item 2(c).
    Citizenship:

    Chai Trust is an Illinois limited liability company.
    EGI-AM Investments is a Delaware limited liability company.
    EGI-AM Investor is a Delaware limited liability company.

    Item 2(d).
    Title of Class of Securities:

    Common Stock, $0.01 par value per share (the “Common Stock”)

    Item 2(e).
    CUSIP Number:

    03980N107

    Item 3.
    If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

    This Item 3 is not applicable.

    Item 4.
    Ownership:

    Item 4(a)
    Amount Beneficially Owned:

    As of September 30, 2024, each of the Reporting Persons may be deemed the beneficial owner of 77,246,499 shares of Common Stock held directly by EGI-AM Investments.

    Item 4(b)
    Percent of Class:

    As of September 30, 2024, each of the Reporting Persons may be deemed the beneficial owner of approximately 54.1% of shares of Common Stock outstanding.  The beneficial ownership percentage reported herein was calculated in accordance with Rule 13d-3(d)(1)(i) and is based on 142,763,328 shares of Common Stock outstanding as of August 14, 2024, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2024.

    Item 4(c)
    Number of Shares as to which such person has:

     
    (i) Sole power to vote or direct the vote:
    0
    (ii) Shared power to vote or direct the vote:
    77,246,499
    (iii) Sole power to dispose or direct the disposition of:
    0
    (iv) Shared power to dispose or direct the disposition of:
    77,246,499

    Item 5.
    Ownership of Five Percent or Less of a Class:

    This Item 5 is not applicable.


    CUSIP No. 03980N107
    SCHEDULE 13G
    Page 6 of 9 Pages
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person:

    See disclosure in Items 2 and 4 hereof.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

    See disclosure in Item 2 hereof.

    Item 8.
    Identification and Classification of Members of the Group:

    This Item 8 is not applicable.

    Item 9.
    Notice of Dissolution of Group:

    This Item 9 is not applicable.

    Item 10.
    Certification:

    This Item 10 is not applicable.


    CUSIP No. 03980N107
    SCHEDULE 13G
    Page 7 of 9 Pages
    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


    CHAI TRUST COMPANY, LLC






    By:
    /s/ Joseph Miron



    Joseph Miron



    Chief Legal Officer

           
      EGI-AM INVESTMENTS, L.L.C.  
           
      By: /s/ Joseph Miron  
        Joseph Miron  
        Vice President
     
           
      EGI-AM INVESTOR, L.L.C.  
           

    By: /s/ Joseph Miron
         Joseph Miron  
         Vice President
     
           
    November 14, 2024







    CUSIP No. 03980N107
    SCHEDULE 13G
    Page 8 of 9 Pages
    EXHIBIT INDEX
     
    Ex.
     
    Page No.
     
     
     
    A
    Joint Filing Agreement
     9

    CUSIP No. 03980N107
    SCHEDULE 13G
    Page 9 of 9 Pages
    EXHIBIT A


    JOINT FILING AGREEMENT

    The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of Ardent Health Partners, Inc. dated as of November 14, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.


    CHAI TRUST COMPANY, LLC






    By:
    /s/ Joseph Miron



    Joseph Miron



    Chief Legal Officer

           
      EGI-AM INVESTMENTS, L.L.C.  
           
      By: /s/ Joseph Miron  
        Joseph Miron  
        Vice President
     
           
      EGI-AM INVESTOR, L.L.C.  
           

    By: /s/ Joseph Miron
         Joseph Miron  
         Vice President
     
           
    November 14, 2024



    Get the next $ARDT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ARDT

    DatePrice TargetRatingAnalyst
    12/17/2024$20.00Neutral
    Analyst
    11/6/2024$22.00 → $19.00Buy → Neutral
    BofA Securities
    10/11/2024$24.00Overweight
    KeyBanc Capital Markets
    8/12/2024$22.00Buy
    BofA Securities
    8/12/2024$18.00Buy
    Loop Capital
    8/12/2024$24.00Overweight
    Stephens
    8/12/2024$21.00Buy
    Citigroup
    8/12/2024$23.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $ARDT
    Leadership Updates

    Live Leadership Updates

    See more
    • Ardent Health Appoints Chief Development Officer to Lead Strategic Growth

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent's existing markets and support the organization's expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent's long-term growth strategy. "We are excited to welcome Chris to Ardent at a pivotal time in our gr

      5/19/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Appoints Robert DeMichiei to Board of Directors

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

      4/3/25 5:27:00 PM ET
      $AP
      $ARDT
      $HCAT
      $WAY
      Fluid Controls
      Industrials
      Hospital/Nursing Management
      Health Care
    • Ardent Health Announces Appointment of Chief Operating Officer and Senior Leadership Promotions

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His

      3/31/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Financials

    Live finance-specific insights

    See more
    • Ardent Health Reports First Quarter 2025 Results

      Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.50 billion 4.0% growth Y/Y Net Income Attributable to Ardent Health $41 million Adjusted EBITDA(1) $98 million 2.5% growth Y/Y Adjusted EBITDAR(1) $139 million

      5/6/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Announces First Quarter 2025 Results Conference Call and Webcast Date

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its first quarter 2025 results after the market closes on Tuesday, May 6, 2025. A conference call will be held the following day, Wednesday, May 7, 2025, at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time

      4/22/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Announces Fourth Quarter and Full Year 2024 Results Conference Call and Webcast Date

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2024 results after the market closes on Wednesday, February 26, 2025. A conference call will be held the following day, Thursday, February 27, 2025, at 9:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior

      2/5/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Ardent Health Partners Inc.

      10-Q - Ardent Health Partners, Inc. (0001756655) (Filer)

      5/7/25 4:31:36 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

      8-K - Ardent Health Partners, Inc. (0001756655) (Filer)

      5/6/25 4:30:35 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • SEC Form DEFA14A filed by Ardent Health Partners Inc.

      DEFA14A - Ardent Health Partners, Inc. (0001756655) (Filer)

      4/8/25 4:49:14 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ardent Health Appoints Chief Development Officer to Lead Strategic Growth

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent's existing markets and support the organization's expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent's long-term growth strategy. "We are excited to welcome Chris to Ardent at a pivotal time in our gr

      5/19/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Reports First Quarter 2025 Results

      Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.50 billion 4.0% growth Y/Y Net Income Attributable to Ardent Health $41 million Adjusted EBITDA(1) $98 million 2.5% growth Y/Y Adjusted EBITDAR(1) $139 million

      5/6/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health to Participate in May Investor Conferences

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that members of the Company's management team will participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on May 13 and 14, 2025, in Las Vegas, Nevada. Members of the management team will participate in a presentation at 11:40 a.m. ET on Wednesday, May 14, 2025. 2025 RBC Capital Markets Global Healthcare Conference on Tuesday, May 20, 2025, in New York City, New York. Members of the management team will participate in a fireside chat at 8:00 a.m. ET that same day. A live audio webcast of these p

      5/5/25 7:30:00 AM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Demichiei Robert was granted 10,073 shares (SEC Form 4)

      4 - Ardent Health Partners, Inc. (0001756655) (Issuer)

      4/4/25 4:47:38 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • SEC Form 3 filed by new insider Demichiei Robert

      3 - Ardent Health Partners, Inc. (0001756655) (Issuer)

      4/4/25 4:41:50 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Chief Operating Officer Caspers Dave covered exercise/tax liability with 2,480 shares and was granted 40,768 shares (SEC Form 4)

      4 - Ardent Health Partners, Inc. (0001756655) (Issuer)

      4/2/25 5:31:49 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $ARDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Director Webb Robert Thomas bought $339,600 worth of shares (20,000 units at $16.98), increasing direct ownership by 99% to 40,275 units (SEC Form 4)

      4 - Ardent Health Partners, Inc. (0001756655) (Issuer)

      11/13/24 4:41:55 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Analyst resumed coverage on Ardent Health Partners with a new price target

      Analyst resumed coverage of Ardent Health Partners with a rating of Neutral and set a new price target of $20.00

      12/17/24 7:27:59 AM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Partners downgraded by BofA Securities with a new price target

      BofA Securities downgraded Ardent Health Partners from Buy to Neutral and set a new price target of $19.00 from $22.00 previously

      11/6/24 7:16:56 AM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • KeyBanc Capital Markets initiated coverage on Ardent Health Partners with a new price target

      KeyBanc Capital Markets initiated coverage of Ardent Health Partners with a rating of Overweight and set a new price target of $24.00

      10/11/24 7:35:47 AM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ardent Health Partners Inc.

      SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

      11/14/24 6:07:29 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by Ardent Health Partners Inc.

      SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

      11/14/24 4:45:09 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by Ardent Health Partners Inc.

      SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

      11/14/24 4:27:52 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care